Sign up to save your podcasts
Or
Share Catalyze Impact Ep. 6 - Innovating Alzheimer's Treatment: Christian Howell on Non-Invasive Neurotherapies and Cognito's Breakthrough Advances
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Catalyze Impact Ep. 6 - Innovating Alzheimer's Treatment: Christian Howell on Non-Invasive Neurotherapies and Cognito's Breakthrough Advances
Send us a text
What if restoring brain health could be as simple as wearing a headset for an hour a day? Join us for a groundbreaking conversation with Christian Howell, CEO of Cognito Therapeutics, as we uncover the innovative technologies transforming Alzheimer's treatment. With roots in the pioneering work of MIT neuroscientists Dr. Li-Huei Tsai and Dr. Ed Boyden and supported by venture capitalist Gerald Chan, Cognito Therapeutics is leading the charge in non-invasive therapies. Learn how their Spectris technology uses 40 Hertz gamma stimulation to offer a significant breakthrough in neuroplasticity and cognitive preservation.
Discover the collaborative spirit driving the future of neuro therapies as we discuss Christian Howell's strategic vision for advancing brain health. Highlighting the significant strides from the Overture phase two trial to the anticipated Hope phase three trial, we explore how these partnerships with academic powerhouses like MIT and regulatory support from the FDA and CMS are crucial for ensuring both the safety and efficacy of new treatments. With a patient-centric approach, Christian and his team are dedicated to making treatment seamless in daily life, transitioning patients from skepticism to empowerment without compromising on safety.
Christian shares his leadership philosophy, drawing inspiration from Medtronic's founder, Earl Bakken, to challenge societal biases toward traditional pharmaceutical approaches. By advocating for physics-based therapies, Cognito aims to revolutionize neurotechnology and establish non-invasive treatments as primary or complementary options for neurodegenerative diseases. With a focus on empowering language and fostering an open dialogue about cognitive health, this episode offers a compelling vision for a future where brain health is as accessible and manageable as any other chronic condition.
#Cognito #Catalyzeimpact #ideagenglobal
Learn more about Cognito Therapeutics here: https://www.cognitotx.com/
View more episodes of The Catalyze Impact Podcast here: https://www.ideagenglobal.com/podcast
View all episodes
By IdeagenSend us a text
What if restoring brain health could be as simple as wearing a headset for an hour a day? Join us for a groundbreaking conversation with Christian Howell, CEO of Cognito Therapeutics, as we uncover the innovative technologies transforming Alzheimer's treatment. With roots in the pioneering work of MIT neuroscientists Dr. Li-Huei Tsai and Dr. Ed Boyden and supported by venture capitalist Gerald Chan, Cognito Therapeutics is leading the charge in non-invasive therapies. Learn how their Spectris technology uses 40 Hertz gamma stimulation to offer a significant breakthrough in neuroplasticity and cognitive preservation.
Discover the collaborative spirit driving the future of neuro therapies as we discuss Christian Howell's strategic vision for advancing brain health. Highlighting the significant strides from the Overture phase two trial to the anticipated Hope phase three trial, we explore how these partnerships with academic powerhouses like MIT and regulatory support from the FDA and CMS are crucial for ensuring both the safety and efficacy of new treatments. With a patient-centric approach, Christian and his team are dedicated to making treatment seamless in daily life, transitioning patients from skepticism to empowerment without compromising on safety.
Christian shares his leadership philosophy, drawing inspiration from Medtronic's founder, Earl Bakken, to challenge societal biases toward traditional pharmaceutical approaches. By advocating for physics-based therapies, Cognito aims to revolutionize neurotechnology and establish non-invasive treatments as primary or complementary options for neurodegenerative diseases. With a focus on empowering language and fostering an open dialogue about cognitive health, this episode offers a compelling vision for a future where brain health is as accessible and manageable as any other chronic condition.
#Cognito #Catalyzeimpact #ideagenglobal
Learn more about Cognito Therapeutics here: https://www.cognitotx.com/
View more episodes of The Catalyze Impact Podcast here: https://www.ideagenglobal.com/podcast